venetoclax
abbvie,roche
['venetoclax', 'mds']
jtcc s dr. james mccloskey and dr. mahar albitar of genomic testing collaborative studied machine learning to predict who will benefit from venetoclax in mal/mds based on ngs profiling. promising results show this could be a tool for rx decisions. #ash2022
John Theurer Cancer Center @HackensackUMC is among the nation's top cancer hospitals with 14 specialized divisions providing the most advanced care possible.